ACP
COCH icon

Arcus Capital Partners’s Envoy Medical COCH Stock Holding History

Arcus Capital Partners’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$125K Hold
187,573
– – 0.04% 118
2025
Q4 		$124K Buy
187,573
+34,705
+23% +$27.5K 0.04% 140
2025
Q3 		$119K Sell
152,868
-34,705
-19% -$47.1K 0.05% 112
2025
Q2 		$266K Hold
187,573
– – 0.12% 102
2025
Q1 		$244K Buy
+187,573
New +$275K 0.1% 103

Other funds holding COCH

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCA
DSG Capital Advisors Edina, Minnesota $704M AUM 34.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Arcus Capital Partners's COCH Position: Q1 2026 in Review

Arcus Capital Partners held its Envoy Medical (COCH) position steady in Q1 2026 at 187,573 shares worth $125K. The position accounts for 0.04% of the portfolio, ranked #118.

Arcus Capital Partners first reported a position in COCH in Q1 2025 and has held it in 5 quarters since. The position peaked at $266K in Q2 2025. 33 funds tracked by Wall St. Rank hold COCH as of Q1 2026.

  • Arcus Capital Partners held 187,573 shares of Envoy Medical worth $125K as of Q1 2026.
  • Arcus Capital Partners left its Envoy Medical share count unchanged in Q1 2026.
  • Envoy Medical made up 0.04% of Arcus Capital Partners's portfolio in Q1 2026, its #118 holding.
  • Arcus Capital Partners first reported a position in Envoy Medical in Q1 2025 and has held it in 5 quarters since.
  • Arcus Capital Partners's Envoy Medical position peaked at $266K in Q2 2025.
  • 33 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2026.

Based on Arcus Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.